Cargando…
Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
SIMPLE SUMMARY: Gastric cancer has the fifth highest incidence among cancers in the world, and it causes the third most cancer-related deaths. In this study, data from patients with HER2-positive advanced gastric cancer who received trastuzumab deruxtecan (T-DXd) were analyzed. Pre-administration of...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030612/ https://www.ncbi.nlm.nih.gov/pubmed/35456340 http://dx.doi.org/10.3390/jcm11082247 |